Is VXF a Good ETF to Buy?
Vanguard’s Extended Market ETF (VXF) is a broad fund made…
Sell
38
GSUN Quote, Financials, Valuation and Earnings
Last price:
$3.32
Seasonality move
:
-33.42%
Day range:
$3.09 - $3.24
52-week range:
$2.21 - $9.93
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.63x
P/B ratio:
8.94x
Volume:
7.7K
Avg. volume:
141.7K
1-year change:
-55.62%
Market cap:
$6.4M
Revenue:
$10.2M
EPS (TTM):
-$2.01
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Golden Sun Health Technology Group has -- downside to fair value with a price target of -- per share.
GSUN vs. S&P 500
-
Over the past 5 trading days, Golden Sun Health Technology Group has underperformed the S&P 500 by -1.43% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Golden Sun Health Technology Group does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Golden Sun Health Technology Group has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Golden Sun Health Technology Group reported revenues of --.
Earnings Growth
-
Golden Sun Health Technology Group has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Golden Sun Health Technology Group reported earnings per share of --.
Enterprise value:
9.1M
EV / Invested capital:
--
Price / LTM sales:
0.63x
EV / EBIT:
--
EV / Revenue:
0.90x
PEG ratio (5yr expected):
-0.03x
EV / Free cash flow:
-1.81x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$2.2M
Return On Assets:
-20.21%
Net Income Margin (TTM):
-61.08%
Return On Equity:
-86.04%
Return On Invested Capital:
-48.28%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-06 | 2024-03-06 | 2024-03-06 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5.1M | $5.5M | $22.1M | $12.1M | $10.4M | |
| Total Assets | $17.4M | $6.6M | $23.4M | $19.4M | $17.1M | |
| Current Liabilities | $19M | $12.6M | $12.6M | $10.8M | $13.6M | |
| Total Liabilities | $24.8M | $14.3M | $14.7M | $15.1M | $16.7M | |
| Total Equity | -$7.4M | -$7.6M | $8.7M | $4.4M | $411.4K | |
| Total Debt | $1.6M | $2.4M | $3.4M | $3.4M | $3.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-06 | 2024-03-06 | 2024-03-06 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
GSUN
Sector
Market Cap
$6.4M
$421.7M
Price % of 52-Week High
32.63%
70.8%
Dividend Yield
0%
0%
Shareholder Yield
--
3.66%
1-Year Price Total Return
-55.62%
-14.58%
Beta (5-Year)
--
0.943
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$3.20
200-day SMA
Sell
Level
$4.94
Bollinger Bands (100)
Buy
Level
2.67 - 3.31
Chaikin Money Flow
Sell
Level
-35.9M
20-day SMA
Buy
Level
$2.96
Relative Strength Index (RSI14)
Buy
Level
56.14
ADX Line
Buy
Level
21.06
Williams %R
Neutral
Level
-74.4444
50-day SMA
Buy
Level
$2.89
MACD (12, 26)
Buy
Level
0.10
25-day Aroon Oscillator
Buy
Level
8
On Balance Volume
Neutral
Level
161.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-1.3851)
Sell
CA Score
(Annual)
Level (-2.8108)
Sell
Beneish M-Score
(Annual)
Level (-1.1638)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (6.7148)
Sell
Piotroski F Score
(Annual)
Level (3)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Golden Sun Health Technology Group Ltd is a holding company. Along with its subsidiaries, it is engaged in the provision of education services and e-commerce business in the People’s Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistics and consulting services. It has also established its wellness brands and an e-commerce platform to promote and sell wellness products. The company operates in the following segments; Education, which generates maximum revenue, and E-commerce.
Stock Forecast FAQ
In the current month, GSUN has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GSUN average analyst price target in the past 3 months is --.
-
Where Will Golden Sun Health Technology Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that Golden Sun Health Technology Group share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Golden Sun Health Technology Group?
Analysts are divided on their view about Golden Sun Health Technology Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Golden Sun Health Technology Group is a Sell and believe this share price will rise from its current level to --.
-
What Is Golden Sun Health Technology Group's Price Target?
The price target for Golden Sun Health Technology Group over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is GSUN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Golden Sun Health Technology Group is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of GSUN?
You can purchase shares of Golden Sun Health Technology Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Golden Sun Health Technology Group shares.
-
What Is The Golden Sun Health Technology Group Share Price Today?
Golden Sun Health Technology Group was last trading at $3.32 per share. This represents the most recent stock quote for Golden Sun Health Technology Group. Yesterday, Golden Sun Health Technology Group closed at $3.24 per share.
-
How To Buy Golden Sun Health Technology Group Stock Online?
In order to purchase Golden Sun Health Technology Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is PM Stock Up So Much?
Shares of cigarette giant Philip Morris (NYSE:PM) have advanced considerably…
Is Nvidia Stock Still Too Expensive or a Smart Buy?
The $2.8 trillion chip juggernaut NVIDIA Corporation (NASDAQ:NVDA) announced Q4…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 39x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $3T
P/E Ratio: 34x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Buy
53
SITM alert for Mar 6
SiTime [SITM] is down 2.98% over the past day.
Buy
71
ASTS alert for Mar 6
AST SpaceMobile [ASTS] is down 6.66% over the past day.
Sell
20
MRNA alert for Mar 6
Moderna [MRNA] is down 2.7% over the past day.
